191 Infos zu Michel Vounatsos

53 Aktuelle Nachrichten

Im Gegensatz zur Facebook-Aktie tendieren die Papiere der US-Biotechwerte wie Amgen und Biogen seit etlichen Jahren lediglich seitwärts. Sorgt ausgerechnet...

— After more than five years at the helm of embattled Biogen Inc., Michel Vounatsos is stepping down as CEO. › news

› finanzen › alzheimer-flop-bringt-bio...

April 27 (Reuters) - Biogen Inc: * BIOGEN SAYS CEO MICHEL VOUNATSOS' TOTAL COMPENSATION FOR WAS $13.7 MILLION - SEC ...

6 Profile in Sozialen Netzwerken

Bekijk het professionele profiel van Michel Vounatsos op LinkedIn. LinkedIn is het grootste zakelijke netwerk ter wereld en stelt professionals als Michel ...

協助Michel Vounatsos等專業人士尋找適合人選、產業專家、業務夥伴。

Check out professional insights posted by Michel Vounatsos,

16 Hobbys & Interessen

FinancialContent fully hosted finance channel

› Pe...

Michel Vounatsos - Chief Executive Officer. Michael Ehlers - Executive Vice President, Research and Development. Jeff Capello - Chief ...

Michel Vounatsos, Chief Executive Officer of Biogen, is pictured at the company's headquarters in Kendall Square in Cambridge, MA on Dec. 4, Get premium,...

2 Business-Profile

Das Organigramm von Biogen zeigt 75 Führungskräfte, einschließlich einschließlich Michel Vounatsos, Jeffrey Capello, Daniel Karp und Robin Kramer

› Mich...

1 Persönliche Webseiten

Michel Vounatsos's Email. Show email and phone number. Cambridge, Massachusetts. Chief Executive Officer @ Biogen. Executive Vice President,...

4 Infos zur Ausbildung

Michel VOUNATSOS est sur Copains d'avant. Pour le contacter, connectez-vous ou inscrivez-vous gratuitement.

› biography

Michel Vounatsos is on the board of PerkinElmer, Inc. (United States) and Chief Executive Officer & Director at Biogen Idec, Inc. (North Carolina) and Chief ... Es fehlt: Rutland" ‎| Muss Folgendes enthalten: Rutland"

Michel Vounatsos is on the board of PerkinElmer, Inc. , L’Institut de RYthmologie et Modélisation Cardiaque and n-Lorem Foundation and Chief Executive Officer...

3 Dokumente

› sites › files

The Company has agreed with its current CEO, Michel Vounatsos, that he will continue to serve as CEO during the interim period. Mr. Vounatsos will remain on ... › Document

... For Management 1k Elect Director Michel Vounatsos For For Management For For Management 1g Elect Director Peter Rutland For For Management 1h ...

1 Allgemeine Veröffentlichungen

› wiki

4 Video- & Audioinhalte

› watch

Michel Vounatsos est président de MSD-Chibret, filiale française de Merck & co, l'un des leaders mondiaux de l'industrie pharmaceutique. Il explique pour...

› video › › biogen-ceo...

▶ 5:05Michel Vounatsos, Biogen CEO, talks the company's commitment to find drugs that slow the progression of ...

4 Meinungen & Artikel

› cnbc › status

Michel Vounatsos (CEO). Products, Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza. Revenue, Decrease US$ billion (2021). Operating income. › wiki › Bi...

› in...

› ...

93 Webfunde aus dem Netz

View Michel Vounatsos' professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Michel Vounatsos discover ...

Michel Vounatsos的LinkedIn 檔案LinkedIn 是全球最大的專業人士社群網站，協助Michel Vounatsos等專業人士尋找適合人選、產業專家、業務夥伴。

Michel VounatsosFollow ... Michel Vounatsos's post. 19 comments. article- comment__guest-image. Sign in to leave your comment ...

Michel Vounatsos's post: This week at the World Economic Forum in Davos, Alzheimer's disease was on the agenda alongside top global and ...

Michel VounatsosFollow. Like 125; Comment 1. Share. LinkedIn; Facebook ... Michel Vounatsos · Follow. #WorldMSDay #MyInvisibleMS #MS.

Sehen Sie sich Michel Vounatsos' vollständiges Profil an – völlig kostenlos. Ihre Kollegen, Kommilitonen und 500 Millionen weitere Fach- und Führungskräfte ...

业界同行，与全球500,000,000 位职场人士一起驰骋职场。 查看Michel的完整档案 ...

Michel VounatsosFollow. Like 193; Comment 5. Share. LinkedIn ... and families affected by ALS and PSP. Published By. Michel Vounatsos ...

Michel VounatsosFollow. Like 244; Comment 9. Share. LinkedIn; Facebook ... all for the good of our patients. Published By. Michel Vounatsos ...

CEO of Biogen Inc (NASDAQ:BIIB) Michel Vounatsos bought 780 shares of BIIB on at an average price of $ a share.

› ...

— (Reuters) -Biogen Inc said on Tuesday that chief executive Michel Vounatsos will step down and that the company is pulling back on selling its ... › news

Biogen Culture and Mr. Michel Vounatsos” is published by Ananya Jain.

Biogen (NASDAQ: BIIB) today announced that its Board of Directors has appointed Michel Vounatsos as Chief Executive Officer and member of ...

› org › org-chart

› mic...

› michel...

CEO Michel Vounatsos talks about hope for an alzheimer's treatment and the need for new payment innovations to make that treatment affordable.

› tags

› Michel-...